See more : Monterey Capital Acquisition Corporation (MCACW) Income Statement Analysis – Financial Results
Complete financial analysis of Panion & Bf Biotech Inc. (1760.TW) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Panion & Bf Biotech Inc., a leading company in the Biotechnology industry within the Healthcare sector.
- N4 Pharma Plc (N4P.L) Income Statement Analysis – Financial Results
- Planet 13 Holdings Inc. (PLTH.CN) Income Statement Analysis – Financial Results
- UOL Group Limited (UOLGF) Income Statement Analysis – Financial Results
- Intact Financial Corporation (IFTPF) Income Statement Analysis – Financial Results
- SiTime Corporation (SITM) Income Statement Analysis – Financial Results
Panion & Bf Biotech Inc. (1760.TW)
About Panion & Bf Biotech Inc.
Panion & Bf Biotech Inc., a biotechnology pharmaceutical company, manufactures and sells various pharmaceutical products in Taiwan. The company offers products in the areas of medical beauty, kidney, respiratory tract, gastrointestinal tract, and body and hair cleaning. It also provides oral drugs and topical preparations; hand and mechanical disinfection, body lotion, and skin disinfection products; and pet health products, including surgical and skin prescriptions. Panion & Bf Biotech Inc. was founded in 1976 and is headquartered in Taipei, Taiwan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.88B | 2.40B | 1.90B | 1.57B | 1.57B | 1.41B | 1.21B | 1.05B | 1.21B | 1.01B | 857.08M | 674.90M | 584.25M | 524.78M | 559.40M |
| Cost of Revenue | 907.48M | 1.08B | 989.07M | 754.61M | 709.64M | 605.36M | 518.10M | 460.77M | 469.17M | 405.33M | 392.28M | 326.96M | 282.52M | 230.92M | 262.18M |
| Gross Profit | 974.40M | 1.32B | 912.14M | 814.03M | 864.31M | 803.38M | 694.38M | 588.48M | 735.89M | 609.07M | 464.81M | 347.94M | 301.73M | 293.86M | 297.22M |
| Gross Profit Ratio | 51.78% | 54.97% | 47.98% | 51.89% | 54.91% | 57.03% | 57.27% | 56.09% | 61.07% | 60.04% | 54.23% | 51.55% | 51.64% | 56.00% | 53.13% |
| Research & Development | 217.04M | 248.50M | 157.71M | 127.02M | 103.42M | 110.69M | 103.64M | 67.77M | 80.06M | 57.99M | 38.70M | 48.63M | 50.58M | 52.55M | 25.17M |
| General & Administrative | 175.94M | 233.91M | 190.32M | 161.78M | 172.20M | 170.64M | 138.17M | 119.98M | 155.76M | 157.53M | 112.09M | 105.64M | 106.64M | 107.74M | 101.16M |
| Selling & Marketing | 425.64M | 422.15M | 396.67M | 398.39M | 345.23M | 299.88M | 307.86M | 274.28M | 340.97M | 329.16M | 300.14M | 241.38M | 191.93M | 188.97M | 166.97M |
| SG&A | 601.58M | 656.06M | 587.00M | 560.16M | 517.44M | 470.52M | 446.02M | 394.26M | 496.73M | 486.69M | 412.22M | 347.02M | 298.57M | 296.70M | 268.13M |
| Other Expenses | 0.00 | -66.58M | 43.53M | 18.91M | 19.53M | 34.88M | 2.09M | 4.08M | -1.08M | 9.93M | 14.42M | 8.66M | 15.91M | 14.35M | 12.77M |
| Operating Expenses | 817.57M | 904.55M | 744.71M | 706.09M | 640.39M | 591.41M | 549.66M | 458.86M | 615.93M | 544.68M | 450.93M | 395.65M | 349.15M | 349.25M | 293.29M |
| Cost & Expenses | 1.73B | 1.98B | 1.73B | 1.46B | 1.35B | 1.20B | 1.07B | 919.63M | 1.09B | 950.01M | 843.20M | 722.61M | 631.67M | 580.17M | 555.47M |
| Interest Income | 6.52M | 1.79M | 638.00K | 2.21M | 4.54M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 74.00K | 84.00K | 54.00K | 147.00K |
| Interest Expense | 11.36M | 7.59M | 14.68M | 4.47M | 1.83M | 63.00K | 117.00K | 334.00K | 72.00K | 11.00K | 5.10M | 6.71M | 6.26M | 5.68M | 5.83M |
| Depreciation & Amortization | 170.39M | 163.55M | 143.62M | 84.14M | 68.37M | 41.21M | 41.60M | 42.20M | 32.85M | 25.89M | 23.19M | 20.11M | 20.20M | 17.70M | 22.49M |
| EBITDA | 327.22M | 504.62M | 343.05M | 181.46M | 296.48M | 253.74M | 186.32M | 171.82M | 152.81M | 90.28M | 51.50M | -15.54M | -13.97M | -12.67M | 40.11M |
| EBITDA Ratio | 17.39% | 21.04% | 18.04% | 11.57% | 18.84% | 20.24% | 15.25% | 16.39% | 12.37% | 9.90% | 6.01% | -2.63% | -2.38% | -2.35% | 7.21% |
| Operating Income | 156.83M | 341.07M | 199.42M | 97.32M | 228.11M | 211.97M | 144.72M | 129.62M | 119.97M | 64.40M | 13.88M | -47.71M | -47.42M | -55.39M | 3.92M |
| Operating Income Ratio | 8.33% | 14.22% | 10.49% | 6.20% | 14.49% | 15.05% | 11.94% | 12.35% | 9.96% | 6.35% | 1.62% | -7.07% | -8.12% | -10.56% | 0.70% |
| Total Other Income/Expenses | 11.88M | -80.56M | 17.31M | -1.97M | -1.82M | 32.41M | -1.58M | -197.00K | -3.78M | 10.17M | 9.32M | 3.13M | 6.99M | 19.34M | 7.87M |
| Income Before Tax | 168.71M | 333.41M | 182.65M | 89.41M | 226.29M | 244.38M | 143.14M | 129.42M | 116.19M | 74.57M | 23.20M | -44.58M | -40.43M | -36.05M | 11.79M |
| Income Before Tax Ratio | 8.97% | 13.90% | 9.61% | 5.70% | 14.38% | 17.35% | 11.81% | 12.33% | 9.64% | 7.35% | 2.71% | -6.60% | -6.92% | -6.87% | 2.11% |
| Income Tax Expense | 91.49M | 151.06M | 78.25M | 61.51M | 64.97M | 85.21M | 52.60M | 39.70M | 43.19M | 27.09M | 7.55M | 9.37M | 5.58M | 16.52M | 10.55M |
| Net Income | 77.22M | 182.35M | 104.40M | 27.90M | 161.33M | 159.17M | 90.54M | 89.72M | 73.00M | 48.27M | 18.15M | -40.56M | -36.26M | -39.31M | 5.09M |
| Net Income Ratio | 4.10% | 7.60% | 5.49% | 1.78% | 10.25% | 11.30% | 7.47% | 8.55% | 6.06% | 4.76% | 2.12% | -6.01% | -6.21% | -7.49% | 0.91% |
| EPS | 0.90 | 2.13 | 1.32 | 0.36 | 2.07 | 2.06 | 1.31 | 1.30 | 1.06 | 0.71 | 0.30 | -0.77 | -0.64 | -0.70 | 0.10 |
| EPS Diluted | 0.90 | 2.12 | 1.32 | 0.36 | 2.07 | 2.05 | 1.31 | 1.29 | 1.06 | 0.70 | 0.29 | -0.76 | -0.64 | -0.70 | 0.10 |
| Weighted Avg Shares Out | 85.74M | 85.74M | 79.18M | 77.87M | 77.87M | 77.44M | 69.15M | 69.10M | 69.02M | 68.30M | 60.13M | 52.45M | 56.76M | 56.23M | 51.07M |
| Weighted Avg Shares Out (Dil) | 85.79M | 85.83M | 79.24M | 77.93M | 77.97M | 77.56M | 69.25M | 69.25M | 69.16M | 69.19M | 61.58M | 53.22M | 56.76M | 56.23M | 51.07M |
Source: https://incomestatements.info
Category: Stock Reports